First-in-class hay fever immunotherapy backed for NHS use

pharmaphorum

Image Credit: pharmaphorum

Please find more details at pharmaphorum

Summary

A once-daily tablet that can help people suffering from hay fever caused by birch tree pollen, Alk-Abell’s Itulazax, has been recommended for NHS use by reimbursement authority NICE.

Source: pharmaphorum

Read More

(0)

Exclusive AI-Powered News Insights (For Members only)

Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!